We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Mechanism Allows Healthy Cells to Maintain Control of Cell Death Proteins

By Biotechdaily staff writers
Posted on 01 Jul 2008
Cancer researchers have identified a molecular mechanism that prevents apoptosis in healthy cells yet triggers cell death after critical DNA damage.

Investigators at the German Cancer Research Center [Deutsches Krebsforschungszentrum] (Heidelberg) worked with a series of "knockout” mice to examine the relationship between the HIPK2 tumor suppressor protein, an important regulator of cell death, and the E3 ubiquitin ligase Siah-1.

They reported in the June 8, 2008, online edition of the journal Nature Cell Biology that while healthy cells constantly produce HIPK2, it immediately binds to Siah-1, which induces HIPK2 polyubiquitination and subsequent destruction by the cell. When normal cells suffer slight DNA damage, they block degradation of HIPK2 by Siah-1 for a short time. When the damage is repaired, the cell immediately resumes HIPK2 degradation. Only in severely damaged cells, such as those with a broken DNA double strand, is Siah-1 degradation of HIPK2 blocked permanently. As a result, HIPK2 accumulates, apoptosis is triggered, and the cell dies.

In some types of cancer cells this mechanism fails to operate. The degradation of HIPK2 by Siah-1 is not inhibited, and cells with damaged DNA proliferate instead of dying.

"Cancer medicine might be able to make use of our discovery,” said senior author Dr. Thomas G. Hofmann, a researcher at the German Cancer Research Center. "For example, we could use a Siah-1 blocker simultaneously with chemotherapy or radiotherapy to get the cells back into the apoptosis program.”


Related Links:
German Cancer Research Center

New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
Gold Member
Hybrid Pipette
SWITCH

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
01 Jul 2008  |   BioResearch

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
01 Jul 2008  |   BioResearch

New Method Simplifies Preparation of Tumor Genomic DNA Libraries
01 Jul 2008  |   BioResearch